| Business Summary | | Waters
Corporation
is
a
holding
company
that
owns
Waters
Technologies
Corporation.
The
Company
operates
in
the
analytical
instrument
industry,
with
manufacturing
and
distribution
expertise
in
three
complementary
technologies.
They
consist
of
high-performance
liquid
chromatography
instruments
(HPLC),
chromatography
columns
and
other
consumables
and
related
service,
mass
spectrometry
instruments
that
can
be
integrated
and
used
along
with
other
analytical
instruments
(especially
HPLC),
and
thermal
analysis
and
rheology
instruments.
Through
Micromass,
Waters
is
engaged
in
the
development,
manufacture
and
distribution
of
mass
spectrometry
instruments,
which
are
complementary
products
that
can
be
integrated
and
used
along
with
other
analytical
instruments,
especially
HPLC.
Through
TA
Instruments,
Inc.,
Waters
is
also
engaged
in
thermal
analysis,
a
prevalent
and
complementary
technique
used
in
the
analysis
of
polymers. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Waters
Corporation
manufactures,
distributes
and
provides
high
performance
liquid
chromatography
instruments,
chromatography
columns
and
other
related
services.
For
the
six
months
ended
6/30/01,
net
sales
rose
8%
to
$407.8
million.
Net
income
before
acct.
change
rose
14%
to
$77.7
million.
Revenues
reflect
increased
sales
to
life
science
customers
across
the
mass
spectrometry
and
HPLC
product
lines.
Earnings
also
reflect
productivity
improvements
and
a
$2.6
million
interest
income. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Douglas Berthiaume, 52 Chairman,
Pres, CEO | $1.5M | $40M | John Ornell, 43 CFO | -- | -- | Arthur Caputo, 49 Sr.
VP, Sales and Marketing | 598K | 24M | Brian Mazar, 43 Sr.
VP of HR, Director of Investor Relations | -- | -- | Thomas Feller, 60 Sr.
VP, E-Bus. Initiative | 524K | 34M | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|